Tim Kelly to lead Caribou’s technical operations strategy and execution CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be disclosed Q2 2024; Caribou plans to initiate.
Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 380,000 shares, a decline of 14.3% from the November 30th total of 443,300 shares. Based on an average daily trading volume, of 327,000 shares, the short-interest […]
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.